Delivery Order SPE2DR25D3015-SPE2DR26F4GF4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,361.07 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60 count) on January 8, 2026, with a completion date of January 9, 2026. This firm fixed-price, competitively awarded delivery order was issued from Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The award carries no set-aside designation, indicating it was competed on a full and open basis. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Risperdal 0.5 mg tablets (60 count) with a ceiling value of $3,787.60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,976.26 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count packages) under a firm fixed-price contract. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a competitively awarded, non-set-aside purchase order for pharmaceutical supply to support federal medical procurement needs. The contractor will perform from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a ceiling value of $3,722.17. This competitively awarded, firm fixed-price delivery order is not set-aside and will be completed by June 13, 2025. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,915.37 to AmerisourceBergen Drug Corp for the supply of Risperidone 3 mg tablets (60-count units). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $1,276.80 to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units, with a ceiling value of $2,008.32. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,675.13 firm fixed-price delivery order for 60 tablets of Risperdal 0.5 mg on December 1, 2025, with completion due by December 2, 2025. This is a non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Risperdal 3 mg tablets in quantities of 60 units, with a ceiling value of $6,678.85 and a firm fixed-price structure. This non-set-aside competitive award is scheduled for completion by September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12,175.63 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract includes performance through September 11, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract carries no set-aside designation, reflecting the contractor's...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4GF4Delivery Order
On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,892.49 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count package). This firm fixed-price delivery order is set to be completed by January 13, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, demonstrating the contractor's capability to meet federal pharmaceutical supply requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The DLA Medical Supply Chain utilizes such contracts to efficiently supply essential prescription medications to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/11/26 |